Literature DB >> 11356518

Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum.

R Durand1, S Jafari, J Vauzelle, J F Delabre, Z Jesic, J Le Bras.   

Abstract

Recent transfection based studies demonstrated that cg2, a candidate gene for chloroquine resistance in Plasmodium falciparum, was not the resistance determinant. A further analysis of the initial 36 kb locus comprising the cg2 gene led to the discovery of another gene, pfcrt, which was absolutely associated with chloroquine resistance in forty parasite lines [Fidock DA, Nomura T, Talley AT, Su XZ, Cooper R, Dzekunov SM, Ferdig MT, Ursos LMB, Sidhu ABS, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000;6:861-71]. The aim of this study was to evaluate, in 146 unselected clinical isolates obtained mostly from non-immune travellers returning from various endemic countries to France in years 1995-1999, the association between in vitro chloroquine resistance and the sequence of a part of the pfcrt gene. For comparison, the determination of the cg2 kappa and the pfmdr1 codon 86 genotypes were also performed on the same isolates. As determined by an isotopic semi-microtest, 70 isolates were susceptible to chloroquine (50% inhibitory concentration<80 nM) and 76 were resistant. The amplification of a portion of the pfcrt gene spanning codons 72-76, followed by sequencing showed three distinct genotypes: one type associated with susceptible isolates, one type associated mostly with resistant isolates and one type found in a resistant isolate originating from South America. Three different zones could be defined according to the status of codon 76. For 50% inhibitory concentration values< or =40 nM (n=47), all isolates but one had K76 (wild type). For 50% inhibitory concentration values located between 40 and 60 nM, isolates had either K76 (n=5) or K76T (mutant type) (n=6). For 50% inhibitory concentration values>60 nM (n=88), all isolates had K76T. A lack of a strong association between the pfmdr1 N86Y mutation and in vitro chloroquine resistance was observed. Cg2 genotypes were less strongly linked than pfcrt genotypes with in vitro chloroquine susceptibility in isolates located below 40 and above 60 nM. Further studies are needed to determine the reliability of the pfcrt gene as a genetic marker for chloroquine resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356518     DOI: 10.1016/s0166-6851(01)00247-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  30 in total

1.  pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia.

Authors:  Pharath Lim; Sophy Chy; Frédéric Ariey; Sandra Incardona; Pektra Chim; Rithy Sem; Mey Bouth Denis; Sean Hewitt; Stefan Hoyer; Doung Socheat; Odile Merecreau-Puijalon; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Rapid detection of a molecular marker for chloroquine-resistant falciparum malaria.

Authors:  Rémy Durand; Virginie Huart; Sayeh Jafari; Jacques Le Bras
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Association between prevalence of chloroquine resistance and unusual mutation in pfmdr-I and pfcrt genes in India.

Authors:  Sabyasachi Das; Subhankari Prasad Chakraborty; Amiya Kumar Hati; Somenath Roy
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

4.  Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.

Authors:  Valérie Andriantsoanirina; Didier Ménard; Stéphane Rabearimanana; Véronique Hubert; Christiane Bouchier; Magali Tichit; Jacques Le Bras; Rémy Durand
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

5.  In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.

Authors:  O A Folarin; C Bustamante; G O Gbotosho; A Sowunmi; M G Zalis; A M J Oduola; C T Happi
Journal:  Acta Trop       Date:  2011-09-06       Impact factor: 3.112

6.  Role of Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes on in vitro chloroquine resistance in isolates of Plasmodium falciparum from Thailand.

Authors:  Chavachol Setthaudom; Peerapan Tan-ariya; Naruemon Sitthichot; Rommanee Khositnithikul; Nantana Suwandittakul; Saovanee Leelayoova; Mathirut Mungthin
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

7.  Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivative.

Authors:  Julie Millet; Sandrine Alibert; Marylin Torrentino-Madamet; Christophe Rogier; Christiane Santelli-Rouvier; Patricia Bigot; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.

Authors:  O A Folarin; G O Gbotosho; A Sowunmi; O O Olorunsogo; A M J Oduola; T C Happi
Journal:  Open Trop Med J       Date:  2008

9.  Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.

Authors:  David J Johnson; David A Fidock; Mathirut Mungthin; Viswanathan Lakshmanan; Amar Bir Singh Sidhu; Patrick G Bray; Stephen A Ward
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

Review 10.  Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.

Authors:  Mark A Travassos; Miriam K Laufer
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.